Motivation: The hydrophobicity of a monoclonal antibody is an important biophysical property relevant for its developability into a therapeutic. In addition to characterizing heterogeneity, Hydrophobic Interaction Chromatography (HIC) is an assay that is often used to quantify the hydrophobicity of an antibody to assess downstream risks. Earlier studies have shown that retention times in this assay can be correlated to amino-acid or atomic propensities weighted by the surface areas obtained from protein 3-dimensional structures. The goal of this study is to develop models to enable prediction of delayed HIC retention times directly from sequence. Results: We utilize the randomforest machine learning approach to estimate the surface exposure of amino-acid side-chains in the variable region directly from the antibody sequence. We obtain mean-absolute errors of 4.6% for the prediction of surface exposure. Using experimental HIC data along with the estimated surface areas, we derive an amino-acid propensity scale that enables prediction of antibodies likely to have delayed retention times in the assay. We achieve a crossvalidation Area Under Curve of 0.85 for the Receiver Operating Characteristic curve of our model. The low computational expense and high accuracy of this approach enables real-time assessment of hydrophobic character to enable prioritization of antibodies during the discovery process and rational engineering to reduce hydrophobic liabilities. Availability and implementation: Structure data, aligned sequences, experimental data and prediction scores for test-cases, and R scripts used in this work are provided as part of the Supplementary
Introduction
Monoclonal antibodies (mAbs) have emerged as a rapidly growing class of therapeutics (Reichert, 2017) with sales expected to reach over $100 billion by 2020 (Ecker et al., 2015) . As of late 2016, over fifty such molecules have been approved, with several hundred more in active clinical development. There exist a plethora of in vivo (Lonberg, 2005; Milstein, 1999) and in vitro (Boder et al., 2012; Chao et al., 2006; Frenzel et al., 2016; Ho and Pastan, 2009; Lerner, 2016; Nixon et al., 2014) technologies for identifying, isolating and optimizing multiple mAbs to achieve high target specificity, potency and biological activity. In addition to desirable functional characteristics, it is important for these molecules to possess good biophysical and pharmacokinetic properties that enable their development into therapeutics. High-throughput experimental Original Paper (Estep et al., 2015; Kelly et al., 2015; Kohli et al., 2015; Liu et al., 2014; Sun et al., 2013) and in silico (Agrawal et al., 2011 (Agrawal et al., , 2015 Chennamsetty et al., 2010; Lauer et al., 2012; Obrezanova et al., 2015; Sharma et al., 2014) approaches for early screening of developability characteristics have been employed to help prioritize lead molecules, inform engineering approaches to improve biophysical characteristics, and flag potential developmental delays. The ability to remain stable and resist aggregation under manufacturing, processing, long-term storage and administration conditions is an important aspect of the developability of a therapeutic protein. An aggregated protein can show loss in activity or present immunogenic epitopes (Jiskoot et al., 2012; Sharma, 2007) . Several distinct mechanisms can drive the aggregation of a protein. Proteins with low conformational stability at the temperature of interest can partially unfold, exposing otherwise buried hydrophobic residues that nucleate formation of typically irreversible aggregates. Similarly, unfolding can also proceed at air-water and glass-water interfaces, leading to aggregation (Amin et al., 2014; Liu et al., 2013) . Folded mAbs can exhibit favorable self-interactions via exposed hydrophobic patches (Chennamsetty et al., 2010) , electrostatic complementarity (Arora et al., 2016; Singh et al., 2014; Yadav et al., 2012) or both (Esfandiary et al., 2015) , with these interactions being dependent on solution conditions such as pH, ionic strength and type of excipient. Delayed retention times (RT) in a chromatographic assay (Kohli et al., 2015) with a hydrophobic matrix were shown to be indicative of a tendency for precipitation in a set of monoclonal antibodies. The same study also found a good correlation between retention times and non-specific interactions as measured by cross-interaction chromatography (CIC), which is another widely used assay used to assess non-specific interactions (Jacobs et al., 2010; Tessier et al., 2004) . While an overall weaker correlation between HIC and CIC was observed in an evaluation on a larger set of mAbs in advanced clinical stages (Jain et al., 2017) , mAbs with delayed HIC RTs showed higher CIC RTs on average. Sequence-based predictions (Agrawal et al., 2011; Wang et al., 2009) for mAbs have identified b-branched aliphatic and aromatic amino-acids as aggregation-prone motifs. A machine learning approach using physico-chemical descriptors of the sequence was successfully developed and used to identify antibodies at higher risk for aggregation (Obrezanova et al., 2015) . While it identified several sequence positions important for aggregation, it was unable to identify a consensus property as a driver for aggregation. Relative to overall surface composition, non-specific interfaces formed by crystal packing are enriched in aliphatic and aromatic amino-acids (Prasad Bahadur et al., 2004) as well. High hydrophobic scores have also been shown to result in poor pharmacokinetics and faster rates of clearance (Sharma et al., 2014) . Accelerated clearance has also been shown to arise from increasing hydrophobicity in antibody-drug conjugates (Lyon et al., 2015) . In an analysis of a polyclonal human antibody pool using HIC, the majority of antibodies eluted at retention times corresponding to low hydrophobicity (Jarasch et al., 2015) . Since HIC can be used to quantify the effective hydrophobicity of a protein close to its native folded state, a successful in silico approach for predicting poor behavior in this assay could provide valuable information to rationally rank and prioritize antibody output at the early discovery stage.
Several computational studies (Hanke et al., 2015; Lienqueo et al., 2006 Lienqueo et al., , 2007 Mahn and Asenjo, 2005; Salgado et al., 2006) have demonstrated the correlation between protein surface characteristics and hydrophobicity measured using HIC. However, these studies have largely employed 3-dimensional protein structures either obtained via X-ray crystallography or homology modeling.
The use of structures representative of the folded state is justified since the assay is carried out in the presence of lyotropic salts that maintain the protein close to its native folded conformation (Hjertén, 1973; Lienqueo et al., 2007) . In this study, we attempt to develop models that enable us to predict the solvent-accessible surface-area (SASA) directly from the amino-acid sequence of the antibody. There exist several tools, for example, ACCpro/ACCpro5 (Magnan and Baldi, 2014; Pollastri et al., 2002) , SABLE (Adamczak et al., 2005) , NETASA (Ahmad and Gromiha, 2002) , MUPRED (Bondugula and Xu, 2008) , PaleAle (Pollastri et al., 2007) and SPIDER2 (Yang et al., 2017b) , that predict the SASA from sequence. We refer the reader to a recent review (Ali et al., 2014) for a comprehensive overview of these methods. To the best of our knowledge, these tools predict SASA at the level of individual chains. Since most antibodies consist of a pair of chains, heavy and light, we develop models that account for the contact patterns and geometric localization conferred by the immunoglobulin fold and chain assembly.
In this study, we aim to make two main contributions to enable prediction of delayed HIC RT from sequence. First, we develop a machine learning model to predict the SASA for each residue in an antibody's variable domain. As detailed in the Section 2, the models are built by training on a set of crystal structures curated from the PDB (Berman et al., 2000) . Second, using experimental HIC RT data on a large set of antibodies and the SASAs from the machine learning models, we estimate amino-acid propensities using logistic regression to best identify antibodies exhibiting a delayed RT.
Materials and methods

Input set of crystal structures
A curated set of 902 antibody crystal structures with kappa light chains and unique complementarity determining regions (CDRs) was used in this study. The sequences were determined using the ATOM records in the structure. The input to the curation process were the PDB structures from RCSB (Berman et al., 2000) as of November 2016. We parsed coordinate entries from the Protein Data Bank (PDB) and performed a sequence alignment of individual chains to human and mouse antibody variable (VH, Vj) and junctional region (JH, Jj) germline sequences obtained from the IMGT database (Lefranc, 2011) . Chains that returned alignments with at least 40 exact matches over the variable region and at least 6 exact matches in the junctional regions were retained, and the type (light or heavy) was assigned using the alignment with the highest identity over the variable region. Within a coordinate entry, pairs of light and heavy chains are assembled to generate the coordinates of the variable (Fv) region. If multiple light and heavy chain copies were present, the pair with the most number of light-heavy residue-residue contacts (using a 5 Å heavy-atom distance cutoff), subject to a minimum of 35 contacts, was designated as the representative Fv. The assignment of pairs was validated by cross-checking against the biological unit information provided in the REMARK 350 section of the PDB header. Structures with missing backbone atoms, except for contiguous segments at the termini, were removed from further analysis. For structures containing identical CDRs, the highest resolution structure was retained in the final set. Except for CDR H3, the residues were re-numbered using the Kabat numbering scheme (Al-Lazikani et al., 1997) . For CDR H3, we adopted a numbering scheme adapted from that proposed by IMGT (Lefranc et al., 2005) . YASARA (Krieger et al., 2009 ) was used to delete crystallographic waters and groups containing heteroatoms, as well as add any missing side-chains. Finally, all side-chains were optimized using steepest-descent minimization with the YASARA2 forcefield. The side-chain SASA at each position in the antibody was calculated for the structures prepared above using the Shrake-Rupley algorithm (Shrake and Rupley, 1973) with a solvent radius of 1.4 Å . The PDB IDs, aligned sequences and calculated values for the SASA are shared in the Supplementary Material.
External dataset of CDR H3 sequences
The igSeqProt and igSeqNt fasta files available from NCBI FTP website (Tao Tao, 2011) were processed in the following manner to extract CDR H3 sequences. The nucleotide sequences were translated to amino-acid sequences in all six reading frames and aligned to human VH germline sequences (Lefranc, 2011) . Sequences with a percent identity less than 75% to any of the germline sequences were discarded, as were sequences containing positions where the amino-acid was undetermined or a stop codon was encountered. A regular expression search was used to extract the CDR H3s using the pattern: The second set of external sequences comprised of the 137 CDR H3s from a recent study (Jain et al., 2017) on the biophysical properties of approved and late-stage clinical mAbs.
Random forest regression
The randomforest (Breiman, 2001 ) machine learning technique was used to build models to predict SASA for the antibody variable regions. The selection of this method was motivated by its ability to deal with correlated (Diaz-Uriarte and Alvarez de Andres, 2006), noisy (Biau, 2012) and mixed numeric and factor datatypes. Furthermore, since it employs learning trees, it can capture nonlinear and discontinuous dependencies between the independent and dependent variables. The use of a random subset of variables and data used in building individual trees makes the method resistant to overfitting. The randomforest machine learning method has been successfully used in antibody modeling tasks such as template selection for CDR H3 modeling (Messih et al., 2014) , prediction of antibody: antigen contacts (Olimpieri et al., 2013) and prediction of heavy chain: light chain orientation (Bujotzek et al., 2015) .
For each position i along the antibody sequence, a separate random forest regressor was trained to predict the SASA using the following model:
where i is an index over positions 1-113 in the heavy-chain and 1-107 in the light-chain, SASA i is the fractional solvent-accessible surface-area calculated from structure at position i, AA i is the type of the amino-acid at the position, VHF and VLF are the heavy-and light-chain germline families, ðCDR LengthsÞ is the set of lengths of the heavy-and light-CDRs and (Neighbor AA to i) are the aminoacids at neighboring positions to i. The amino-acids in the model were encoded using a numeric value corresponding to the rank of the amino-acid when ordered by increasing maximum exposed side-
The maximum exposed side-chain SASAs in the Ala-X-Ala (Chennamsetty et al., 2010) peptides were used to convert the absolute SASA to fractional values between 0 and 1. Approximately 0.2% of the normalized SASA values exceeded 1.0. These were set to 1.0 before the regression was performed. To reduce the complexity, size and running time of the model, we limited the set of neighbors in the model. Using the 902 input structures, we calculated the probability that two positions were in contact using a Cb-Cb cutoff of 12 Å . The set of positions in contact with the target position with a probability exceeding 0.5 were used in equation 1. The above model was compared with a model where the SASA at a position is a function of only the amino-acid type at that position,
Models built using equations 1 and 2 will be referred to as the detailed and simple models, respectively. Models to predict the backbone SASA were also built employing the same formalism as discussed above. The randomForest (Liaw and Wiener, 2002) package (version 4.6-12) in R 3.2.4 was used to fit the model with 2500 trees. The trial values for mtry were N/1, N/3, or N/5, where N is total number of independent variables in the model equation. For nodesize, the values tested were 1, 3, 5 or 10. The reader is referred to the documentation (Liaw and Wiener, 2002) for a discussion of these parameters. A combinatorial grid was generated over these two sets of values, and the final model was chosen based on the lowest out-ofbag (OOB) error. All other parameters were set to their default values. The R script to build the models is included in the Supplementary Material.
Hydrophobic interaction chromatography
The methodology for this assay was described previously (Estep et al., 2015) . In brief, 5 lg IgG samples (1 mg/ml) were spiked in with a mobile phase A solution (1.8 M ammonium sulfate, 0.1 M sodium phosphate at pH 6.5) to achieve a final ammonium sulfate concentration of about 1 M prior to analysis. A Sepax Proteomix HIC butyl-NP5 column was used with a liner gradient of mobile phase A and mobile phase B solution (0.1 M sodium phosphate, pH 6.5) over 20 min at a flow rate of 1 ml/min with UV absorbance monitoring at 280 nm. A reference IgG1 antibody sample corresponding to the variable regions of adalimumab was run periodically to assess the reproducibility of the assay. Over 127 separate assessments of the reference antibody, the retention times (RT) were 8.6 6 0.12 min.
For antibodies that were produced in both HEK293 and yeast cells, we observed an excellent agreement of the HIC RTs between samples produced in either host. For the rest of the analysis, no further distinction was made based on the host system.
Antibody set for HIC assay
The antibodies used in this study were expressed in either HEK293 or yeast cells. HIC retention times were collected for 5089 unique antibody sequences. These antibodies belonged to heavy chain families VH1, VH3 and VH4, and light chain families Vj1, Vj2, Vj3 and Vj4. The average identity to the closest human germline sequences is 96.7 6 4% for the heavy chain, and 98.6 6 3% for the light chain. The CDR H3s were grouped such that any pair of H3s in different clusters either differed in length, or had an amino-acid mismatch at more than two positions. This process resulted in 2065 clusters. The dataset was partitioned based on these clusters to generate training and cross-validation sets for coefficient determination using logistic regression. While differing in detail, a similar approach of partitioning sequences into training and test sets on the basis of similarity was also used in another study focused on developing machine learning models to predict aggregation risk of antibodies (Obrezanova et al., 2015) .
Antibodies that eluted 2 min later versus earlier than the reference antibody were classified as having a delayed versus normal RT. The choice of this threshold was motivated by physical and statistical considerations. The threshold of 2 min was considered physically meaningful as it is approximately the 75th percentile value over the set of 48 approved antibodies (Jain et al., 2017) , thus providing an external benchmark of highly characterized and functionally validated sequences. Additionally, choosing this threshold maintains a significant diversity of sequences in each category, enabling development of a more robust model. Using this threshold, 26% of the 5089 antibodies showed a delayed RT. Approximately 3% of the antibodies did not elute from the column and were considered to belong to the delayed category.
Logistic regression
Two logistic regressions were performed to fit per amino-acid type coefficients to discriminate antibodies with delayed HIC retention times using either the SASA determined by the randomforest model or the counts of the amino-acid types. The logistic regression models are defined by the following equations,
where p is the probability of an antibody belonging to the delayed category, a and b are intercepts of the model, i is an index is over the amino-acid types, S and N are the surface area and counts, and, u and r are the amino-acid propensities fit to maximize the likelihood of the observed data. R was used to estimate the propensities in the above equation using two statistical subroutines, glm and glmnet (Friedman et al., 2010) . The glmnet routine was run using parameters that regularize the fit using a LASSO penalty (Tibshirani, 1996) term i.e. the l1-norm of the absolute value of the coefficients.
Assessment of accuracy
The 2065 CDR H3 clusters were randomly split into training (66%) and cross-validation (33%) sets. The goal of this process was to ensure that the cross-validation set was materially different than the set used to fit the logistic models. The training set was used to estimate the coefficients in equations 3 and 4 using logistic regression. The score for the antibodies in the cross-validation was computed by the right-hand side of the same equations using the fitted coefficients and the SASAs predicted using the randomforest models or the counts over amino-acid types. The Area Under Curve (AUC) obtained from the Receiver Operating Characteristic (ROC) curve and the Brier scores (Brier, 1950) were used to evaluate the performance on the cross-validation set. The Brier score for a binary prediction is the mean-square error between the predicted probabilities and the event outcome. A statistical comparison of the performance glm, glmnet and the literature amino-acid property indices was carried out by repeating the fitting procedure over one hundred random splits of the input data into training and cross-validation sets.
Results
Prediction of SASA from sequence
The randomforest (Breiman, 2001 ) algorithm is a type of an ensemble learning method that constructs a collection of decision or regression trees using different subsets of input data for each individual tree. Since the randomforest method uses a subset of data to fit each tree, it enables an assessment of the error by averaging predictions for a data point from trees that do not use that data point in their construction. Such a prediction is known as the out-ofbag (OOB) prediction. Figure 1 plots the SASA calculated directly from structure against the OOB predictions from the detailed model fit using equation 1, for the six CDRs. Supplementary Figure S1 shows the prediction over the framework regions. To assess errors in the SASA on account of variations in the crystal structures, we performed an analysis where we identified sets of structures with an identical sequence but different PDB ID. These structures were processed in the same manner as the curated set used for building the randomforest models. For each position along the antibody, the average SASA was calculated from 3-d coordinates of the structures within a set. Using the difference between the average SASA and the individual SASA, error estimates were calculated in the same manner as for the predictions from the models. We believe these estimates provide a conservative lower bound on the accuracy of predicting SASA. Table 1 summarizes and compares the performance of the detailed model, the simple model which does not incorporate neighbor, germline family or CDR length information and the error estimates from the crystal structures. The simple model which is based solely on position and amino-acid identity performs well, indicating that the primary signal in the prediction arises from the position itself, which is expected given the limited structural variation seen in antibodies outside of CDR H3. However, the detailed model consistently outperforms the simple model on all metrics considered, indicating that the incorporation of local neighborhood information and global sequence descriptors leads to improved predictions. Supplementary Figure S2 shows the improvement in RMSE per amino-acid type over the six CDRs for the detailed model compared to the simple model, further highlighting the improved predictions from the former. For non-H3 CDRs, root-mean-square errors (RMSE) and mean-absolute errors (MAE) are under 10% and 6% of the fractional SASA, respectively. It is not surprising that the Fig. 1 . SASAs from crystal structures vs. OOB predictions from the randomforest models for the six CDRs. Since the absolute values of SASA depend on amino-acid type and differ in range, the normalized values of SASA are plotted to enable the use of a single scale largest MAE of 8.2% is for CDR H3, which has the largest sequence and conformational diversity (North et al., 2011; Sivasubramanian et al., 2009; Weitzner et al., 2015) . While significant progress has been made, challenges still remain in building accurate atomic-level models for the CDR H3 (Marks and Deane, 2017) . In an assessment of de novo modeling of antibody structure, deviations from the crystal structures were higher for the H3 compared to the other CDRs (Almagro et al., 2014; Sivasubramanian et al., 2009; Zhu et al., 2014) . The CDR H3 also exhibits larger changes in conformation and solvent accessibility on antigen binding (Sela-Culang et al., 2012) compared to the remainder of the Fv, indicating its larger inherent plasticity. Conversely, the errors in the predicted SASA were the smallest for the framework (FR) regions, which show high structural conservation. However, these errors are approximately twofold higher in the detailed model than the estimates from the crystal structures, indicating room for further improvement in the models, either through alternate machine learning methodologies or tuning of models for individual positions. This line of investigation was not pursued further since the incorporation of FR SASAs did not improve predictions of delayed HIC RT (Section 3.2). Supplementary Figure S3 plots the total Fv SASA in Å 2 obtained from the predictions against the calculations directly from PDB structures. In percentage terms, the RMSE and MAE errors for the total SASA are 2.5 and 1.9%, respectively, indicating good predictions of overall Fv SASA.
Since the machine learning approach infers patterns from existing structures, a limitation of the current approach is that predictions can be inaccurate for new input sequences with features that are not well represented in the training set of structures. For example, the above scenario can arise if a sequence has a CDR length, and thus a position(s) in the sequence, for which no or very few representative structures exist in the database. Since the randomforest learner behaves like an adaptive nearest-neighbor (Lin and Jeon, 2002) method, the predictions for such positions will tend towards the mean of the observations in the representative structures, which is a reasonable approximation. For the non-H3 CDRs, the variation in lengths and conformations is limited (Al-Lazikani et al., 1997; North et al., 2011) and can be modeled accurately through the use of existing structures. To assess the coverage of the current models for CDR H3, we consider the overlap in distributions between the lengths of unique CDR H3s in the 902 structures used in this work and two external datasets. The first dataset consists of sequences from the NCBI FTP site (Tao Tao, 2011) . The second dataset is based on a significant subset of the antibodies that are approved therapeutics or in advanced stages of clinical development (Jain et al., 2017) . Supplementary Figure S4 shows the distributions for the above sets. Approximately 25 or more PDB structures exist for each CDR H3 length from 9 to 18. These lengths represent 87 and 76% of the clinical and NCBI datasets respectively. For the set of antibodies used in this study to build models for HIC prediction, 91% of the CDR H3 clusters lie within this length range. Even across different CDR H3 lengths, positions in the so-called torso region show limited conformational variability (Morea et al., 1998; North et al., 2011) . For such positions, the machine learning model will attempt to use information over all CDR H3 lengths present in the training set of PDB structures. It is expected that retraining the model as additional structures become available will continue to improve predictions.
Since the focus of this study is to predict the HIC behavior for antibodies, we have restricted ourselves to the relevant subset of structures from the PDB. In principle, the above methodology can be extended to other families of proteins with a multiplicity of 3D structures, either experimental or generated via in silico approaches.
Prediction of delayed HIC RT
A logistic model was built to discriminate antibodies exhibiting retention time later than 2 min compared to the reference sample. The functional form of the logistic model is consistent with prior use of surface-area weighted amino-acid propensities to estimate, fit or analyze characteristics of proteins. A few examples of such approaches are the detection of aggregation-prone regions (Chennamsetty et al., 2010) , modeling transfer solvation energies (Eisenberg and McLachlan, 1986; Wimley et al., 1996) , estimating binding free energies (Zhou and Zhou, 2002) and predicting HIC RT (Hanke et al., 2015; Lienqueo et al., 2006; Mahn and Asenjo, 2005) . The inputs to this model were the CDR SASAs predicted from the randomforest model and experimental HIC data collected on 5089 unique antibodies. Figure 2A shows the coefficients for each amino-acid type obtained from this fit, with positive values indicating a propensity toward delayed HIC RT. The charged amino acids have negative values, and the aliphatic and aromatic amino-acids have positive values, indicating that the fit captures the essential physical interactions present in the assay. Figure 2B shows the ROC curve for this model with an AUC of 0.87. A threshold value of -2.05 for the score leads to a true positive rate (TPR) of 95% and a true negative rate (TNR) of 47.7%. Discrimination using this threshold would eliminate most antibodies with a delayed HIC RT while still retaining a significant fraction of those that elute normally. Conversely, if the objective is to retain most antibodies that elute normally, using a threshold of 0.25 results in a TNR of 95% and a TPR of 49%. Finally, the distribution of scores between the two classes of antibodies is shown in Figure 2C . One hundred and twelve antibodies in this set are approved or in advanced stages of clinical development. The Supplementary Material lists the variable region sequences, the HIC RTs and the predictions from the glmnet model obtained using equation 3, for these antibodies. The ROC curve over this subset yields an AUC of 0.85, which is comparable to the overall performance of the model. For 40 of the antibodies within this set, a crystal structure with identical or nearly identical sequence is available in the PDB. Nine out of these 40 antibodies exhibit a delayed HIC RT. Equation 3 was used to compute the score using the SASAs calculated from these structures along with the coefficients obtained from the glmnet fit. The resulting AUC value was 0.82. The score computed using the SASAs from the randomforest models led to a comparable AUC value of 0.84, further highlighting the suitability of this approach. The details of this analysis are given in the Supplementary Material.
Using the SASAs over the entire variable region instead of just the CDRs, resulted in a minor loss of performance as assessed by an average AUC of 0.82 over the cross-validation sets. This observation is consistent with the development of the SAP-score (Lauer et al., 2012) , where including regions beyond the CDR did not impact the relative ranking of mAbs on the calculated metric. Similarly, no statistically significant improvements were seen for either including the heavy and light chain germline families or predicted backbone SASAs into the logistic regression.
Comparison of coefficients to existing amino-acid property indices
We compared the coefficients obtained from the glmnet fit with the 533 amino-acid property indices from the AAindex database (Kawashima et al., 2008) as available in the R package Interpol (Heider and Hoffmann, 2011) . We found four indices that had an absolute Pearson correlation coefficient, r, of greater than 0.9 to the coefficients determined in this study. Supplementary Table S1 lists the indices identified by this analysis. The indices identified in this manner were originally derived based on burial tendencies (Zhou and Zhou, 2004) , organic solvent to water transfer free-energies (Nozaki and Tanford, 1971) and estimated contributions to HPLC retention times (Meek, 1980; Meek and Rossetti, 1981) , for aminoacids. Since the values from these indices are on different scales, we rescaled them into a range from -1 to 1, taking care to negate values for the indices where the correlation coefficients were negative. Figure 3 compares the coefficients determined in this work with an average over the four indices after rescaling. The individual coefficients for these scales and the propensities determined in this study are provided in the Supplementary Material.
Using the protocol for generating training and cross-validation sets as detailed in Section 2, a comparison of the performance was carried out between the coefficients obtained using glmnet with LASSO penalty, glm, the coefficients from the Black-Mould (BM) hydrophobicity scale (Black and Mould, 1991) , and the four scales identified earlier. In keeping with the recommendation for the SAPscore (Lauer et al., 2012) , we additionally evaluated the performance using only the BM coefficients that are positive (BMp). Figure  4 shows that the best performance over the cross-validation sets is obtained using the glmnet model with a median AUC of 0.85 and a Brier score of 0.135. It is not surprising that glmnet outperforms glm, since regularization using the LASSO penalty reduces overfitting to the training dataset and improves generalization. The logistic model developed using equation 4 uses only counts of amino-acids in the CDRs, and is shown as count in Figure 4 . The performance of this model trails that of the model using predicted SASA as judged by both the AUC and the Brier score metrics, indicating the importance of incorporating SASA into the models. Both logistic models developed in this work outperform the literature indices, though the median AUC for all the indices is greater than 0.77. Given the unbalanced proportions of delayed and normal RT antibodies, we additionally used the Area Under the Precision Recall Curve (AUPRC) metric (Davis and Goadrich, 2006) to evaluate the performance of the glmnet model and the literature amino-acid scales over the entire dataset. Supplementary Figure S5 shows that the best performance is achieved using models developed in this work.
Discussion
In this work, we have developed a machine learning model to predict the residue-level SASA from a given antibody sequence. Such an approach could be generalized to the prediction of other structural metrics that are relevant for the developability of an antibody. For example, the underlying methodology used for calculating the SAPscore (Lauer et al., 2012) was recently extended for estimating charge heterogeneity and its ability to predict viscosity (Agrawal et al., 2015) . Neural networks sharing the same architecture have been used to predict different structural properties such as secondary structure (Magnan and Baldi, 2014) , number of residue neighbors and solvent-accessibility (Magnan and Baldi, 2014; Pollastri et al., 2002) . Our earlier work has used SASAs estimated in this fashion to predict oxidation labile methionines in antibodies (Yang et al., 2017a) . The structure and sequence conservation of the framework regions and limited number of canonical conformations for the non-H3 CDRs enables such an endeavor. As in de novo modeling of antibody structures, accurate prediction of H3 remains a challenge and is an active area of research. While an accurate model of the H3 is likely essential for tasks such as antigen recognition or in silico affinity maturation, getting reasonable estimates for surface exposure without the constraints of obtaining atomic-level accuracy appear to suffice for the predictions considered in this work.
Using an extensive set of experimental HIC data in conjunction with the estimated SASA, we derived a set of amino-acid propensities that achieve high accuracy in classifying antibodies with delayed retention times. It is reassuring that the propensities obtained from a purely statistical fit correlate with existing indices aiming to capture similar biophysical interactions. Incorporating information about the extent of heterogeneity of the protein surface using descriptive statistics (Hanke et al., 2015; Salgado et al., 2006) has shown promising results for predicting HIC RTs. Identification of aggregation hotspots via detection of hydrophobic patches (Chennamsetty et al., 2010) has been used to rationally engineer resistance to aggregation. Further improvements to the predictive models could require incorporation of such metrics and will be pursued as a future line of investigation. Including SASAs for the framework regions did not lead to improvements in predicting delayed HIC RTs. This could be a consequence of the antibody set used in this study containing framework regions that are essentially identical to human germlines. We hypothesize that any non-specific hydrophobic interactions contributed by these regions would have negative consequences selected out by evolution.
Since the models developed in this work to predict delayed HIC RT do not depend on 3-dimensional structures, obtained either via crystallography or homology modeling, they enable a real-time assessment of hydrophobicity at the earliest stages of discovery where hundreds or even thousands of sequences could be analyzed. For in vitro technologies that rely on a designed synthetic diversity (Knappik et al., 2000; Mao et al., 2010; Zhai et al., 2011) , such predictions can enable optimization of in silico library design, enabling antibody libraries that have favorable developability characteristics by design. The product of the SASA and the amino-acid propensity provides the contribution of individual amino-acids, and thus naturally informs a rational approach of mutagenesis to engineer desirable behavior. With initial prioritization done using these methods, homology models could be built at a later stage to investigate the finer structural metrics predictive of developability, resulting in a scalable in silico pipeline.
